References

  1. Hsu, et al. GSJ. 2012;2:239–248.
  2. Medtech 360 report “Orthopedic Biomaterials Market Analysis 2017”.
  3. Mabud, et al. Clin Spine Surg. 2017;30:E1376–E1381.
  4. Chun, et al. Neurosurgical Focus. 2015;39(4):E10.
  5. Epstein, et al. SNI. 2017;8:61
  6. Morris, et al. ESJ. 2018;27:1856–1867.
  7. Van Dijk, et al. Clin Spine Surg. 2019;33(6):E276-E287.
  8. Lindfors, et al. J Biomed Mater Res. 2002;63(2):237-44.
  9. Rantakokko, et al. Scandinavian Journal of Surgery. 2012;101:66–71.
  10. Frantzen, et al. J Spinal Disord Tech. 2011;24:455–461.
  11. Cook, et al. Spine (Phila Pa 1976). 1995;15,20(8):877-86.
  12. Suhardi JV, et al. J Biomed Mater Res. 2020;108B:2354–2367.
  13. Ng VY. Orthopedics. 2012;1;35(8):679-81.
  14. Van Dijk, et al. JOR Spine. 2018;e1039.
  15. James, et al. Tissue Engineering: Part B. 2016;22:4.
  16. Olthof, et al. J Tissue Eng Regen Med. 2018;12(6):1339-1351.
  17. Wang, et al. Spine (Phila Pa 1976). 2013;1;38(17):1452-8.
  18. Hu, et al. Tissue Eng Part A. 2019;25(19-20):1356-1368
  19. Bae HJ, et al. Bone Joint Surg Am. 2010;92(2):427-35.
  20. Russel N, et al. Front. Surg. 2020;7:10
  21. Gruskin E, et al. Adv Drug Deliv Rev. 2012;64(12):1063-77.
  22. Buser Z, et al. Global Spine Journal. 2018,8(4):396-412.
  23. Tilkeridis et al. World J Orthop. 2014;18; 5(1): 30-37.
  24. Axelsen, et al. JOSR. 2019;14:2.
  25. Sherman, et al. Eur Spine J. 2010;19(12):2156-63.
  26. Mobbs, et al. J Neurosurg Spine. 2014;21:867-76.
  27. Lauweryns, et al. Int J Spine Surg. 2015;9:2.
  28. Hing, et al. Spine J. 2007;7(4):475-90.
  29.  Van Dijk, et al. J Biomed Mater Res. Part B: Appl Biomater. 2019;107(6):2080-2090. 
  30. Mendelson, et al. Aesth Plast Surg. 2010;34(4):455-61.
  31. Hing, et al. Biomaterials. 2006;27:5014–5026.
  32. Godoy, et al. J Mater Sci Mater Med. 2015;26-54.
  33. Barbagallo, et al. Eur Spine J. 2013;22:(Suppl 6)S868–S878.
  34. Nagineni, et al. Spine (Phila Pa 1976). 2012;15,37(20):E1264-7.
  35. Jenis, et al. Spine (Phila Pa 1976). 2010;15,35(20):E1058-6.
  36. Pimenta, et al. J Neurol Surg A Cent Eur Neurosurg. 2013;74(6):343-50.
  37. Alimi, et al. Clin Spine Surg. 2017;30:E845–E852.
  38. Licina, et al. Global Spine J. 2015;5(6):471-8.
  39. Coughlan, et al. Spine (Phila Pa 1976). 2018;1;43(15):E860-E868.
  40. Berg, et al. Global Spine Journal. 4(1_suppl), s-0034-1376731-s-0034-1376731.
  41. Van Dijk, et al. eCM. 2021;41:756-73.
  42. Duan, et al. eCM. 2019;37:60-73.
  43. Data on File.

 

 

*MagnetOs has been proven to generate more predictable fusions than two commercially available alternatives in an ovine model of posterolateral fusion. Results from in vivo laboratory testing may not be predictive of clinical experience in humans. For important safety and intended use information please refer to the Instructions for Use for a full list of indications, contraindications, precautions, and warnings. 

PROMO_MAG_EU_005-21 Aug '21